Literature DB >> 23202541

Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer.

Hiroyuki Suzuki1, Hideya Onishi, Takashi Morisaki, Masao Tanaka, Mitsuo Katano.   

Abstract

Previously, we have shown that CD8(+)T/FOXP3(+) cell ratio but not FOXP3(+) cell number alone is an independent prognostic factor for colorectal cancer. In the present study, we evaluated whether the number of intratumoral FOXP3(+)VEGFR2(+) (itFOXP3(+)VEGFR2(+)) T cells alone could be a predictive factor for survival prognosis in patients with colorectal cancer. Distribution of regulatory T cells (Tregs) at tumor sites derived from 88 patients with primary colorectal cancer was fluorescence-immunohistochemically examined. Relatively low number of itFOXP3(+)VEGFR2(+) cells significantly correlated with better [corrected] disease-free survival (DS) and overall survival (OS); multivariate analysis indicated that number of itFOXP3(+)VEGFR2(+) cells is an independent predictive and prognostic factor of DS and OS while neither intratumoral FOXP3(+) cell number nor intratumoral FOXP3(+)VEGFR2(-) cell number alone showed significant correlation with DS or OS. These results suggest that FOXP3(+)VEGFR2(+) may be a better predictive Treg marker than FOXP3(+) alone for recurrence and survival in patients with colorectal cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23202541     DOI: 10.1016/j.clim.2012.10.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

1.  Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer.

Authors:  Patrick J Schuler; Malgorzata Harasymczuk; Bastian Schilling; Zenichiro Saze; Laura Strauss; Stephan Lang; Jonas T Johnson; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

Review 2.  Colorectal cancer and immunity: what we know and perspectives.

Authors:  Simon Pernot; Magali Terme; Thibault Voron; Orianne Colussi; Elie Marcheteau; Eric Tartour; Julien Taieb
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

Review 3.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

4.  CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer.

Authors:  Michelle Hong; Jian Hang Lam; Si-Lin Koo; Clarinda Wei Ling Chua; Kah Ling Lim; Felicia Wee; Wei Keat Wan; Wei Qiang Leow; Joo Guan Yeo; Iain Bee Huat Tan; Joe Yeong; Tony Kiat Hon Lim; Tong Seng Lim
Journal:  Cancer Immunol Immunother       Date:  2021-02-02       Impact factor: 6.630

5.  The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis.

Authors:  Peipei Xu; Wei Fan; Zheng Zhang; June Wang; Ping Wang; Yirong Li; Mingxia Yu
Journal:  Front Physiol       Date:  2017-11-21       Impact factor: 4.566

Review 6.  The role and significance of VEGFR2+ regulatory T cells in tumor immunity.

Authors:  Panrong Zhu; Chenxi Hu; Kaiyuan Hui; Xiaodong Jiang
Journal:  Onco Targets Ther       Date:  2017-09-01       Impact factor: 4.147

7.  Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis.

Authors:  Guoming Hu; Zhi'an Li; Shimin Wang
Journal:  Oncotarget       Date:  2017-06-07

8.  Home sweet home: the tumor microenvironment as a haven for regulatory T cells.

Authors:  Beatrice Ondondo; Emma Jones; Andrew Godkin; Awen Gallimore
Journal:  Front Immunol       Date:  2013-07-16       Impact factor: 7.561

9.  CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.

Authors:  J Y Liu; F Li; L P Wang; X F Chen; D Wang; L Cao; Y Ping; S Zhao; B Li; S H Thorne; B Zhang; P Kalinski; Y Zhang
Journal:  Br J Cancer       Date:  2015-08-18       Impact factor: 7.640

10.  Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta analysis.

Authors:  Yong Huang; Huaiwei Liao; Yong Zhang; Rongfa Yuan; Fengmei Wang; Yingtang Gao; Peng Wang; Zhi Du
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.